Cognitive decline in geriatric oncology: Trends, evaluation and treatment

Bulletin du cancer
V AntoineM Viala

Abstract

Cancer prevalence increases with aging. Prevalent or incident neurocognitive disorders are frequent in geriatric oncology. Cognitive decline associated with cancer increases the risk of under or over-cancer treatment and makes therapeutic decisions complex. In this context, we present tools to optimize cognitive impairment screening, identification of underlying mechanisms and specific treatments. Geriatric specialists intervention can help global care, social services utilization and patient's orientation when ambulatory cares become difficult.

Citations

Oct 26, 2021·Bulletin du cancer·Valery AntoineLaurent Balardy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Related Papers

Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses
Gabrielle Burdeu
Virginia Medical Quarterly : VMQ
P W Houck
Revista de neurologia
M C Etchepareborda
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses
Thomas BuckleyGeoffrey Tofler
© 2022 Meta ULC. All rights reserved